pyridostigmine bromide has been researched along with Heart Failure in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Accornero, F; Baine, S; Belevych, A; Bonilla, I; Carnes, CA; Dorn, LE; Gyorke, S; Stepanov, A; Terentyev, D; Terentyeva, R | 1 |
| Pan, A | 1 |
| da Silva, CA; Fazan, R; Giusti, H; Glass, ML; Sabino, JP; Salgado, HC | 1 |
| Fazan, R; Godinho, RO; Lataro, RM; Prado, CM; Rossi, MA; Salgado, HC; Silva, CA | 1 |
| Costa, RV; Nóbrega, AC; Serra, SM; Teixeira De Castro, RR; Xavier, SS | 1 |
| da Silva, CA; de Melo, RF; Fazan, R; Sabino, JP; Salgado, HC | 1 |
| Sueta, CA | 1 |
| Behling, A; Ferlin, EL; Moraes, RS; Nóbrega, AC; Ribeiro, JP; Rohde, LE | 1 |
2 trial(s) available for pyridostigmine bromide and Heart Failure
| Article | Year |
|---|---|
Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure.
Topics: Acetylcholinesterase; Adaptation, Physiological; Analysis of Variance; Autonomic Nervous System; Cholinesterase Inhibitors; Cross-Over Studies; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pyridostigmine Bromide; Receptors, Cholinergic; Risk Factors; Stroke Volume | 2009 |
Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.
Topics: Administration, Oral; Aged; Arrhythmias, Cardiac; Cardiac Output, Low; Cholinesterase Inhibitors; Cross-Over Studies; Double-Blind Method; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Parasympathetic Nervous System; Pyridostigmine Bromide; Statistics, Nonparametric; Time Factors | 2003 |
6 other study(ies) available for pyridostigmine bromide and Heart Failure
| Article | Year |
|---|---|
Pyridostigmine improves cardiac function and rhythmicity through RyR2 stabilization and inhibition of STIM1-mediated calcium entry in heart failure.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Cholinesterase Inhibitors; Heart Failure; Male; Mice; Mice, Inbred C57BL; Pyridostigmine Bromide; Ryanodine Receptor Calcium Release Channel; Stromal Interaction Molecule 1 | 2021 |
Penumbral role of beta blockade on heart rate recovery in heart failure.
Topics: Animals; Heart; Heart Failure; Heart Rate; Parasympathetic Nervous System; Pyridostigmine Bromide; Rats | 2018 |
Parasympathetic activation by pyridostigmine on chemoreflex sensitivity in heart-failure rats.
Topics: Animals; Cholinesterase Inhibitors; Disease Models, Animal; Heart Failure; Heart Rate; Hypercapnia; Hypoxia; Male; Parasympathetic Nervous System; Pulmonary Ventilation; Pyridostigmine Bromide; Rats; Rats, Wistar | 2013 |
Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure.
Topics: Animals; Cholinesterase Inhibitors; Heart; Heart Failure; Heart Rate; Male; Parasympathetic Nervous System; Pyridostigmine Bromide; Rats; Rats, Wistar; Vagus Nerve; Ventricular Dysfunction | 2013 |
The treatment with pyridostigmine improves the cardiocirculatory function in rats with chronic heart failure.
Topics: Animals; Baroreflex; Cardiotonic Agents; Cholinesterase Inhibitors; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Evoked Potentials; Heart; Heart Failure; Heart Rate; Ligation; Male; Myocardium; Parasympathetic Nervous System; Pyridostigmine Bromide; Random Allocation; Rats; Rats, Wistar; Sympathetic Nervous System | 2013 |
Heart rate variability in chronic heart failure: target for therapy?
Topics: Arrhythmias, Cardiac; Cholinesterase Inhibitors; Heart Failure; Heart Rate; Humans; Parasympathetic Nervous System; Pyridostigmine Bromide | 2003 |